WeChat-Based Nursing Interventions in Women's Mobile Health: Systematic Review
Abstract
Background: Mobile health (mHealth) technology offers new approaches to improve women's health by providing personalized monitoring and real-time guidance. As one of the most widely used social media platforms in China, WeChat has shown great potential in mHealth practice, yet systematic evidence on its application in women's health care remains insufficient.
Objective: This study aims to systematically review WeChat-based nursing interventions in women's mHealth in order to clarify the application status, intervention modalities, target populations, and effectiveness outcomes.
Methods: Searches were conducted in IEEE Xplore, Web of Science, PubMed, Scopus, ACM Digital Library, and Cochrane Central Register of Controlled Trials between January 2011 and December 2024. Two independent reviewers screened studies; extracted data on study design, intervention forms, target diseases, and outcome indicators; and assessed methodological quality. The Cohen κ coefficient was used to evaluate interreviewer agreement. Publication trends, institutional collaborations, author contributions, and research hotspots were analyzed using VOSviewer (Leiden University) and InCites (Clarivate) for bibliometric analysis.
Results: A total of 31 eligible studies published from 2014 to 2024 were included. Most studies were randomized controlled trials (n=27). Intervention modalities mainly included WeChat groups (n=22), official accounts (n=18), applets (n=4), and private chats (n=9), mostly used in…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 27 participants or records.
Read the paper
Related studies
- Increased expression of circulating miRNA-93 in women with polycystic ovary syndrome may represent a novel, non-invasive biomarker for diagnosis
- Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
- Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules
- Regulation of Androgen Receptor Expression Alters AMPK Phosphorylation in the Endometrium: In Vivo and In Vitro Studies in Women with Polycystic Ovary Syndrome
- Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome
- Systems pharmacology to investigate the interaction of berberine and other drugs in treating polycystic ovary syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.